Mechanistically, PRDM15 regulates a transcriptional program that sustains the activity of the PI3K/AKT/mTOR pathway and glycolysis in B-cell lymphomas. The gene discussed is AKT1; the disease is B-cell non-Hodgkin lymphoma.